Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
HBAR targets $0.32 after blasting through the $0.24 resistance level

HBAR targets $0.32 after blasting through the $0.24 resistance level

CoinjournalCoinjournal2025/07/14 18:20
By:Coinjournal
HBAR targets $0.32 after blasting through the $0.24 resistance level image 0

Key takeaways

  • Hedera’s HBAR is the third-best performer among the top 20 cryptocurrencies by market cap.
  • The coin is targeting the $0.32 resistance level after overcoming $0.24 a few hours ago.

HBAR rallies as BTC sets a new all-time high

The cryptocurrency market is having a positive start to the week thanks to rallies by Bitcoin, Ether, XRP, HBAR, and other major coins and tokens. The rally comes after last week’s excellent performance and could extend further as investors prepare for a crucial week in the United States.

Bitcoin has set a new all-time high of $122,800 a few minutes ago after adding 4% to its value in the last 24 hours. Ether and XRP, the two leading altcoins, are also trading in the green.

HBAR, the native coin of the Hedera blockchain, is up 10% in the last 24 hours, making it the third-best performer among the top 20 cryptocurrencies by market cap. The coin has now surpassed the $0.24 resistance level and could rally higher soon.

HBAR targets $0.32 as bulls look to extend rally

The HBAR/USD 4-hour chart is bullish but inefficient, suggesting that the pair could sweep liquidity to the downside before embarking on any upward rally. The technical indicators are bullish, suggesting a further rally in the near to medium term.

The Relative Strength Index (RSI) of 74 shows that HBAR is heading into the overbought region if the positive momentum holds. Furthermore, the MACD lines are within the positive zone, indicating a bullish bias.

HBAR targets $0.32 after blasting through the $0.24 resistance level image 1

If the bulls remain in control, HBAR could rally towards the first major resistance level at $0.28452, last tested on March 2nd. In the event of an extended rally, HBAR could retest the $0.32281 level for the first time since January. 

However, if the bulls fail to leverage this momentum, HBAR could retest the ILQ level at $0.22556 in the coming hours or days. An extended bearish condition would see HBAR drop to the TLQ level at $0.19152.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

As AI controversies escalate, hedge funds buy tech stocks at the fastest pace in 15 months

Hedge funds have recorded net purchases of US TMT stocks on 10 out of the past 11 trading days, rebuilding tech long positions at the fastest pace in 15 months. However, an AI policy storm has struck at the "worst possible time"—calls by AI giants to slow down development have been rejected, and regulatory uncertainty has directly hit Asian tech stocks such as Softbank. As the tech sector's bullish run coincides with Super Central Bank Week, the sector now faces a severe test.

华尔街见闻2026/09/14 07:03

Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind

According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.

华尔街见闻2026/09/14 06:42

UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs

In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.

智通财经2026/09/14 06:36
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs